Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients

Acta Cardiologica

Volumn 66, Issue 4, 2011, Pages 465-470

  Ding, Wei ^a   Zhou, Linuo ^a   Bao, Yuanyuan ^a   Zhou, Lixue ^b   Yang, Yehong ^a   Lu, Bing ^a   Wu, Xi ^a   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Baroreflex sensitivity; Diabetes; Heart rate variability; Hypertension

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHINESE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POWER SPECTRUM; PRESSORECEPTOR REFLEX;

AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEART; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 80051998318     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.4.2126595     Document Type: Article

References (21)

1. Kardos A, Watterich G, de Menezes R, Csanády M, Casadei B, Rudas L. Determinants of spontaneous baroreflex sensitivity in a healthy working population. Hypertension 2001; 37: 911-916.
2. Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P, Holme I, Heiss G. Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens 1996; 9: 1147-1156.
3. Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17(3): 354-381.
4. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985: 8(5): 491-498.
5. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 2001; 19(1): 157-161.
6. Bertinieri G, DiRienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol 1988; 254: H377-H383.
7. Zhou L, Yu M, Zhu X, Fan H, Cheng M, Shen Z, Duan W. Correlation of spectral analysis of heart rate fluctuations with classical cardiovascular autonomic function tests in NIDDM patients. Chinese J Diabetes 1997; 15: 110-111.
8. Pagani M. Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 2000; 13(6): 341-346.
9. Whitworth JA, Chalmers J. World health organization-international society of hypertension (WHO / ISH) hypertension guidelines. Clin Exp Hypertens 2004; 26: 747-752.
10. Wu G, Wu Y, Sheng L, Tang D, Zhao N. Impairment of baroreflex sensitivity in hypertensive patients. J Shanghai Med Univ 1999; 3: 172-175 [in Chinese].
11. Sleight P. The importance of the autonomic nervous system in health and disease. Aust N Z J Med 1997; 27: 467-473.
12. Parmer RJ, Cervenka JH, Stone RA. Baroreflex sensitivity and heredity in essential hypertension. Circulation 1992; 85: 497-503.
13. Huang Y, Zhou LN, Wu GQ, Dong XH, Hu RM. Detecting diabetic cardiovascular autonomic neuropathy by power spectral analysis of heart rate variability (HRV), baroreflex sensitivity (BRS) and blood pressure variability (BPV) in hypertensive and normotensive diabetic patients. Chinese Journal of Diabetes 2009; 1: 46-48 [in Chinese].
14. Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S, Hara M, Sakino H, Katsuragi I, Okeda T, Yoshimatsu H, Sakata T. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 2001; 38(1): 232-237.
15. Pagani M, Malfatto G, Pierini S, Casati R, Masu AM, Poli M, Guzzetti S, Lombardi F, Cerutti S, Malliani A. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv System 1988; 23: 143-153.
16. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000; 86: 309-312.
17. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Länsimies EA, Uusitupa MI, Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48(6): 1295-1299.
18. Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E, Ciampittiello G, Menzinger G, Gambardella S. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003; 41: 1223-1227.
19. Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Review 2006; 2: 329-338.
20. Haider AW, Larson MG. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham heart study. Ann Intern Med 2003; 138: 10-16.
21. Bakris GL, Fonseca V, Katholi RE, Mcgill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA, Anderson KM, Bell DS. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004, 292: 2227-2236.